Adam Ang | 01:57 am | December 19, 2025

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.

By Adam Ang | 01:56 am | December 19, 2025

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

By Adam Ang | 02:23 am | December 16, 2025

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.

By Adam Ang | 02:58 am | December 15, 2025

HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.

By Adam Ang | 02:03 am | December 11, 2025

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

By Adam Ang | 08:20 pm | December 10, 2025

Screening rates in northern Queensland lag behind the statewide average.

By Adam Ang | 08:20 pm | December 10, 2025

The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.

By Adam Ang | 07:15 pm | December 04, 2025

It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.

By Adam Ang | 07:07 am | December 02, 2025

The Korean AI company also plans expansion into Vietnam and Hong Kong.

By Adam Ang | 07:07 am | December 02, 2025

Trained on local medical laws and treatment guidelines, the model scored 96.4 on the 2025 Korean Medical Licensing Examination.